Predicting neonatal acute respiratory distress syndrome using perinatal factors
Optimization and Clinical Study of Early Prediction Model for Neonatal Acute Respiratory Distress Syndrome
This study looks at how certain factors around birth can help predict if newborns will develop acute respiratory distress syndrome to improve understanding and potentially lower risks for babies.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 1 Minute and up |
| Sex | All |
| Sponsor | University-Town Hospital of Chongqing Medical University Academic / other |
| Locations | 2 sites (Chongqing, Chongqing and 1 other locations) |
| Trial ID | NCT05647850 on ClinicalTrials.gov |
What this trial studies
This observational study aims to investigate neonatal acute respiratory distress syndrome (ARDS) by analyzing perinatal factors that may help predict its occurrence. The study will collect umbilical cord blood from newborns to assess these factors without administering any interventions. By identifying early predictors of ARDS, the research seeks to enhance understanding and potentially reduce mortality associated with this condition in neonates.
Who should consider this trial
Good fit: Ideal candidates for this study are newborns who are born alive and meet the inclusion criteria.
Not a fit: Patients who are stillborn or have existing respiratory conditions or congenital anomalies will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved early prediction of neonatal ARDS, potentially reducing mortality rates in affected infants.
How similar studies have performed: While the approach of using perinatal factors for prediction is not widely tested, similar studies in neonatal care have shown promise in improving outcomes through early identification of risks.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * A newborn born alive Exclusion Criteria: * Stillborn newborn * Respiratory distress syndrome(RDS), transient tachypnoea of the neonate (TTN), or congenital anomalies as a primary current acute respiratory condition * Hereditary endocrine and metabolic diseases * Incomplete records
Where this trial is running
Chongqing, Chongqing and 1 other locations
- University-Town Hospital of Chongqing Medical University — Chongqing, Chongqing, China (Recruiting)
- Women and Children's Hospital of Chongqing Medical University — Chongqing, Chongqing, China (Recruiting)
Study contacts
- Principal investigator: Hui Liu — University-Town Hospital of Chongqing Medical University
- Study coordinator: Hui Liu
- Email: liuhui8805@126.com
- Phone: +8615223013501
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.